SAMe (Joints).

Methionine synthase needs B12 to remethylate homocysteine back to methionine, the amino acid SAM-e is made from. Without it, SAM-e use raises homocysteine instead of recycling it.

5-methyltetrahydrofolate is the methyl donor that methionine synthase transfers to homocysteine. Folate and B12 together keep the methionine cycle turning when SAM-e is supplied.

B6 drives the transsulfuration branch that moves homocysteine onward to cysteine. It gives the methionine cycle a downstream exit rather than only a recycling loop.

Betaine donates a methyl group to homocysteine through BHMT, a folate-independent route back to methionine. It is the standard companion for keeping homocysteine in range during SAM-e use.

Methionine adenosyltransferase makes SAM-e from methionine and ATP, and both the enzyme and ATP handling depend on magnesium. Magnesium status underlies endogenous SAM-e production.

Cartilage proteoglycans are heavily sulfated, and SAM-e feeds the transsulfuration route that supplies sulfate. Glucosamine sulfate delivers both the amino sugar backbone and sulfate for the same matrix.

MSM contributes bioavailable sulfur to connective tissue, complementing the sulfur SAM-e releases through transsulfuration.

Chondroitin is a sulfated glycosaminoglycan of cartilage, and its sulfation depends on the body's sulfate pool that methionine metabolism feeds.

SAM-e breakdown feeds homocysteine into the pathway that produces cysteine, the same residue NAC supplies directly. The two converge on the cysteine and glutathione pool.

Boswellic acids act on the 5-lipoxygenase branch of eicosanoid signalling while SAM-e works through methylation and sulfate supply to cartilage. The mechanisms do not overlap.

Curcumin modulates NF-kB signalling in joint tissue, a separate route from the methylation and sulfation chemistry SAM-e supports.

Collagen peptides supply the amino acid pattern of the cartilage fibre network while SAM-e supports the sulfated ground substance around it.

SAM-e influences monoamine methylation and 5-HTP raises serotonin synthesis, so the two are additive on serotonergic signalling. This is a caution to record rather than a benefit to promote.

St John's wort slows serotonin reuptake while SAM-e acts on monoamine metabolism, an additive combination on the same signalling system that warrants care.

SAMe is synthesised from methionine and ATP by methionine adenosyltransferase, so methionine availability is the upstream limit on how much SAMe the body makes. Supplemental SAMe bypasses that step and enters the cycle downstream. The two sit on the same line, one before the other.

MTHFR needs FAD, built from riboflavin, to produce the 5-methyltetrahydrofolate that returns homocysteine to methionine. That regeneration is what keeps the methionine pool available for SAMe synthesis. Riboflavin status is therefore part of the same cycle as the folate and B12 partners already listed.

Creatine synthesis consumes a large share of the body's SAMe methyl groups at the guanidinoacetate methyltransferase step. Supplying creatine from the diet reduces endogenous synthesis and therefore the methyl demand placed on SAMe. The relationship is well described biochemically and is the clearest example of one supplement changing another's methyl economy.

Glycine N-methyltransferase is the overflow valve of the methylation cycle: it methylates glycine to sarcosine specifically to dispose of excess SAMe and hold the SAMe to SAH ratio steady. Glycine availability therefore influences how much SAMe is buffered rather than used. This is regulation, not competition for a benefit.

Choline is oxidised to betaine, which donates a methyl group to homocysteine through BHMT and regenerates methionine independently of folate and B12. That is the second of the two remethylation routes feeding SAMe synthesis. Choline and folate status partly substitute for one another in this respect.

Phosphatidylethanolamine N-methyltransferase makes phosphatidylcholine using three successive SAMe methyl donations, one of the largest methyl sinks in the liver. Dietary phosphatidylcholine reduces the need for that route. As with creatine, supplying the product lowers the methyl demand on SAMe.

BHMT is a zinc metalloenzyme, with the zinc atom activating the homocysteine thiol for methyl transfer, and methionine synthase also carries a zinc site. Zinc status therefore sits inside homocysteine remethylation alongside folate, B12 and betaine. It is a structural cofactor requirement rather than a dose-response effect.

Serine donates its beta carbon to tetrahydrofolate through serine hydroxymethyltransferase, which is the main source of one-carbon units entering the folate cycle. Those units become the methyl group that regenerates methionine. Serine is thus the raw material at the far upstream end of SAMe supply.

Chain elongation of chondroitin and keratan glycosaminoglycans runs on manganese-dependent glycosyltransferases. Sulfation of those chains then draws on activated sulfate. Formulations aimed at joint tissue structure need both the metal cofactor and the sulfur donor, which is why the two appear together.

Prolyl and lysyl hydroxylases require ascorbate to keep their iron centre reduced, and without that step collagen triple helices do not fold stably. Cartilage and the tissues around a joint are collagen-rich. Ascorbate is therefore a standing requirement for connective tissue turnover independent of anything SAMe does.

Homocysteine leaving the SAMe cycle can be committed to cysteine, which is then oxidised toward taurine or toward sulfate. Taurine is one terminal sink of that sulfur. It marks where the pathway that begins at SAMe eventually ends.

Hyaluronan is the unsulfated backbone of the matrix that the sulfated glycosaminoglycans attach around. It is combined with SAMe in joint blends on structural reasoning about the same tissue. No trial has measured the combination, so read it as formulation convention.

Bromelain is a proteolytic enzyme complex from pineapple stem, used in joint comfort blends alongside SAMe. There is no shared biochemical step between them. The pairing is commercial practice and food-timing changes how much enzyme activity survives.

Sulfur leaving the SAMe cycle through cysteine catabolism passes through sulfite, and molybdenum-dependent sulfite oxidase converts that sulfite to sulfate. Sulfate is what the sulfation reactions of cartilage matrix ultimately draw on. Molybdenum status is a small but non-optional part of that chain.